Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy

The care of systemic amyloidosis has improved dramatically due to improved awareness, accurate diagnostic tools, the development of powerful prognostic and companion biomarkers, and a continuous flow of innovative drugs, which translated into the blooming of phase 2/3 interventional studies for ligh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuvolone, Mario, Girelli, Maria, Merlini, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788438/
https://www.ncbi.nlm.nih.gov/pubmed/36555787
http://dx.doi.org/10.3390/ijms232416145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788438/
https://www.ncbi.nlm.nih.gov/pubmed/36555787
http://dx.doi.org/10.3390/ijms232416145

Ejemplares similares